Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1978 Jan;62(1):31–38. doi: 10.1111/j.1476-5381.1978.tb07003.x

Subcellular distribution of etorphine in rat brain and evidence for in vitro stereospecific binding.

C Cerletti, P Coccia, L Manara, T Mennini, M Recchia
PMCID: PMC1667779  PMID: 620097

Abstract

1 Control experiments were carried out by homogenizing rat brain at 0 degrees C with sucrose containing various concentrations of [3H]-etorphine. Subcellular fractionation of this homogenate showed that the distribution of the labelled drug amongst the primary fractions was dependent on the concentration of etorphine in the homogenate. 2 Rats were injected intravenously with 0.2 and 20 microgram/kg of [3H]-etorphine. The brains were homogenized and fractionated in sucrose containing 4.2 x 10(-5) M unlabelled etorphine in order to control redistribution artifacts. Different distribution profiles in the subcellular fractions were observed at these two dose levels. 3 Concurrent administration of either cyprenorphine or naloxone with intravenous etorphine, caused a shift of the labelled drug from the P3 fraction to the supernatant fraction. 4 The subcellular distribution of intravenously administered [3H]-etorphine was also studied by homogenizing brains in etorphine-free sucrose, and sucrose containing either levorphanol or dextrorphan. From these experiments it was concluded that the P3 microsomal fraction is a major site to which in vivo etorphine is stereospecifically bound in the rat brain.

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECKETT A. H., CASY A. F. Synthetic analgesics: stereochemical considerations. J Pharm Pharmacol. 1954 Dec;6(12):986–1001. doi: 10.1111/j.2042-7158.1954.tb11033.x. [DOI] [PubMed] [Google Scholar]
  2. Bareggi S. R., Carminati P., Manara L. Metaraminol and monoamineoxidase activity in the rat heart. Res Commun Chem Pathol Pharmacol. 1971 May;2(3):347–354. [PubMed] [Google Scholar]
  3. Blane G. F., Boura A. L., Fitzgerald A. E., Lister R. E. Actions of etorphine hydrochloride, (M99): a potent morphine-like agent. Br J Pharmacol Chemother. 1967 May;30(1):11–22. doi: 10.1111/j.1476-5381.1967.tb02108.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COX B. M., WEINSTOCK M. QUANTITATIVE STUDIES OF THE ANTAGONISM BY NALORPHINE OF SOME OF THE ACTIONS OF MORPHINE-LIKE ANALGESIC DRUGS. Br J Pharmacol Chemother. 1964 Apr;22:289–300. doi: 10.1111/j.1476-5381.1964.tb02034.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clouet D. H., Williams N. Localization in brain particulate fractions of narcotic analgesic drugs administered intracisternally to rats. Biochem Pharmacol. 1973 Jun 1;22(11):1283–1293. doi: 10.1016/0006-2952(73)90302-x. [DOI] [PubMed] [Google Scholar]
  6. Goldstein A., Lowney L. I., Pal B. K. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1742–1747. doi: 10.1073/pnas.68.8.1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. JOHNSON M. K. The intracellular distribution of glycolytic and other enzymes in rat-brain homogenates and mitochondrial preparations. Biochem J. 1960 Dec;77:610–618. doi: 10.1042/bj0770610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kosterlitz H. W., Watt A. J. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Br J Pharmacol Chemother. 1968 Jun;33(2):266–276. doi: 10.1111/j.1476-5381.1968.tb00988.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Leysen J., Laduron P. Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain. Life Sci. 1977 Jan 15;20(2):281–288. doi: 10.1016/0024-3205(77)90323-x. [DOI] [PubMed] [Google Scholar]
  11. MELLETT L. B., WOODS L. A. The intra cellular distribution of N-C14-methyl levorphanol in brain, liver and kidney tissue of the rat. J Pharmacol Exp Ther. 1959 Feb;125(2):97–104. [PubMed] [Google Scholar]
  12. Manara L., Carminati P., Mennini T. In vivo persistent binding of 3 H-reserpine to rat brain subcellular components. Eur J Pharmacol. 1972 Oct;20(1):109–113. doi: 10.1016/0014-2999(72)90223-3. [DOI] [PubMed] [Google Scholar]
  13. Manara L., Mennini T., Carminati P. Reduced binding of 3 H-reserpine to the hearts of 6-hydroxydopamine-pretreated rats. Eur J Pharmacol. 1972 Jan;17(1):183–185. doi: 10.1016/0014-2999(72)90288-9. [DOI] [PubMed] [Google Scholar]
  14. Manara L., Mennini T., Cerletti C. 3H-reserpine persistently bound "in vivo" to rat brain subcellular components: limited removal by peanut oil extraction. Life Sci. 1974 Jun 1;14(11):2267–2276. doi: 10.1016/0024-3205(74)90108-8. [DOI] [PubMed] [Google Scholar]
  15. Mule S. J., Casella G., Clouet D. H. Localization of narcotic analgesics in synaptic membranes of rat brain. Res Commun Chem Pathol Pharmacol. 1974 Sep;9(1):55–77. [PubMed] [Google Scholar]
  16. Mulé S. J., Casella G., Clouet D. H. The specificity of binding of the narcotic agonist etorphine in synaptic membranes of rat brain in vivo. Psychopharmacologia. 1975 Oct 31;44(2):125–129. doi: 10.1007/BF00420998. [DOI] [PubMed] [Google Scholar]
  17. Mulé S. J., Redman C. M., Flesher J. W. Intracellular disposition of H3-morphine in the brain and liver of nontolerant and tolerant guinea pigs. J Pharmacol Exp Ther. 1967 Aug;157(2):459–471. [PubMed] [Google Scholar]
  18. Pert C. B., Snowman A. M., Snyder S. H. Localization of opiate receptor binding in synaptic membranes of rat brain. Brain Res. 1974 Apr 12;70(1):184–188. doi: 10.1016/0006-8993(74)90228-5. [DOI] [PubMed] [Google Scholar]
  19. Pert C. B., Snyder S. H. Opiate receptor: demonstration in nervous tissue. Science. 1973 Mar 9;179(4077):1011–1014. doi: 10.1126/science.179.4077.1011. [DOI] [PubMed] [Google Scholar]
  20. Simon E. J., Hiller J. M., Edelman I. Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A. 1973 Jul;70(7):1947–1949. doi: 10.1073/pnas.70.7.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Smith A. P., Loh H. H. The sub-cellular localization of stereo-specific opiate binding in mouse brain. Res Commun Chem Pathol Pharmacol. 1976 Oct;15(2):205–219. [PubMed] [Google Scholar]
  22. Terenius L. Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol (Copenh) 1973;33(5):377–384. doi: 10.1111/j.1600-0773.1973.tb01539.x. [DOI] [PubMed] [Google Scholar]
  23. Van Praag D., Simon E. J. Studies on the intracellular distribution and tissue binding of dihydromorphine-7,8-H3 in the rat. Proc Soc Exp Biol Med. 1966 May;122(1):6–11. doi: 10.3181/00379727-122-31036. [DOI] [PubMed] [Google Scholar]
  24. Whittaker V. P., Michaelson I. A., Kirkland R. J. The separation of synaptic vesicles from nerve-ending particles ('synaptosomes'). Biochem J. 1964 Feb;90(2):293–303. doi: 10.1042/bj0900293. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES